Delivery Order SPE2DB22D1106-SPE2DB24FEGM8
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ephedrine Sulfate 50 mg/mL injectable medication, with a firm fixed price ceiling value of $1,085.38 and a performance period extending through June 16, 2025. The contract is not set aside and was awarded as an open competition. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ephedrine Sulfate 50 mg/mL in vial form. The contract is valued at $2,127.78 and carries a firm fixed price structure with an ultimate completion date of August 18, 2025. This award represents a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract is...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,104.50 firm-fixed-price delivery order is for the supply of 4562851036 - EPHEDRINE 50 MG/10 ML VIAL 10ML. The contract has a period of performance through November 20, 2023 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,379.10 for the supply of Ephedrine Sulfate 50 mg/mL, a medication that can be used to treat conditions like low blood pressure and asthma. The contract has an ultimate completion date of July 10, 2025 and is a Firm Fixed Price contract. This appears to be part of a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ephedrine Sulfate 50 mg/mL in vial format. This firm fixed price delivery order, valued at $1,287.16, represents a non-competitive set-aside award and is scheduled for completion by September 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award is for the delivery of Ephedrine Sulfate 50 mg/mL Injection to the Defense Logistics Agency (DLA). The contract, valued at $1,418.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ephedrine Sulfate 50 mg/ml vials. The contract has a firm-fixed-price of $1,066.32 and runs through September 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs,...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ephedrine Sulfate, a pharmaceutical product, with a ceiling value of $1,469.52 and an ultimate completion date of April 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,066.44 Firm Fixed Price Delivery Order is for the supply of Ephedrine Sulfate 50 mg/mL vials. The award has no set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $4,430.93 firm fixed price delivery order is for the supply of ephedrine sulfate injection. No set-aside designation was used. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and related distribution services to the Department of...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEGM8Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,074.55, is for the delivery of 4,564,060,192 milliliters of Ephedrine Sulfate 50 mg/mL to support military treatment programs and facilities. This delivery order is part of a broader indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 3/23/24 |